Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou company information, Employees & Contact Information

Explore related pages

Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou email format Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou management contacts

Related company profiles:

Le GORTEC (Groupe d'Oncologie Radiothérapie Tête Et Cou) a été créé en 1999 à partir de cinq centres fondateurs (Clermont-Ferrand, Nancy, Nantes, Tours et Villejuif) dans le but de coordonner la réalisation d'études cliniques et/ou biologiques dans le domaine de la cancérologie cervico-faciale. -Réseau multidisciplinaire d'environ 500 Investigateurs: Chirurgiens, Radiothérapeutes, Oncologues, Radiologues. -Réseau de + de 100 structures de soins en oncologie établis en France, Suisse, Belgique, Tunisie, Allemagne, Espagne -Essais cliniques nationaux et internationaux : Phase III (majoritaires), Phase II & Phase I. -Membre fondateur et moteur de l’Intergroupe ORL labellisée par l’INCa (Institut National du Cancer) depuis 2012 Plus de 150 membres (Médecins référents) Plus de 40 salariés Organisation des réunions scientifiques bi-annuelles (>150 participants)

Company Details

Employees
38
Founded
-
Address
2 Bd Tonnellé, Chu Bretonneau – B47,france
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
Website
gortec.fr
Keywords
Oncologie, Radiotherapie, Chirurgie, Cancers ORL, Cancérologie, Chimiotherapie, ORL, Recherche Clinique, Essais cliniques.
HQ
Tours, France
Competitors
GERCOR, ILC - Institut inter-régionaL de Cancérologie, Unicancer, AFCOR_ Association de Formation Continue en Oncologie Radiothérapie, FFCD, SFjRO-Société Française des Jeunes Radiothérapeutes Oncologues, SFRO - Société Française de Radiothérapie Oncologique, Société Française d'ORL - SFORL, Gustave Roussy, IFCT.
Looking for a particular Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou employee's phone or email?

Gortec - Groupe D'oncologie Radiothérapie Tête Et Cou Questions

News

GORTEC Announces New Trial Success for Head and Neck Cancer Treatment - PR Newswire

GORTEC Announces New Trial Success for Head and Neck Cancer Treatment PR Newswire

ASCO 2025 - For the first time in 20 years, a new treatment shows benefit in high-risk head and neck cancers - Gustave Roussy

ASCO 2025 - For the first time in 20 years, a new treatment shows benefit in high-risk head and neck cancers Gustave Roussy

Nivolumab/Cisplatin/Radiotherapy Improves DFS in Locally Advanced SCCHN - CancerNetwork

Nivolumab/Cisplatin/Radiotherapy Improves DFS in Locally Advanced SCCHN CancerNetwork

Post-Operative Nivolumab Significantly Improves DFS in Head and Neck Cancer - Targeted Oncology

Post-Operative Nivolumab Significantly Improves DFS in Head and Neck Cancer Targeted Oncology

NIVOPOSTOP Trial Demonstrates DFS Benefit of Adjuvant Nivolumab in High-Risk HNSCC Following Chemoradiotherapy - ASCO Daily News

NIVOPOSTOP Trial Demonstrates DFS Benefit of Adjuvant Nivolumab in High-Risk HNSCC Following Chemoradiotherapy ASCO Daily News

Adjuvant Nivolumab Plus Chemoradiotherapy Meets DFS End Point in Locally Advanced HNSCC - OncLive

Adjuvant Nivolumab Plus Chemoradiotherapy Meets DFS End Point in Locally Advanced HNSCC OncLive

Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial - The Lancet

Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial The Lancet

Nivolumab May Enhance Outcomes with SOC Therapy for Locally Advanced HNSCC - CancerNetwork

Nivolumab May Enhance Outcomes with SOC Therapy for Locally Advanced HNSCC CancerNetwork

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial - ScienceDirect.com

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial ScienceDirect.com

Study Finds Durvalumab Plus Carboplatin and Paclitaxel Effective, Tolerable in Frail Patients With Head and Neck Cancer - The ASCO Post

Study Finds Durvalumab Plus Carboplatin and Paclitaxel Effective, Tolerable in Frail Patients With Head and Neck Cancer The ASCO Post

Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial - The Lancet

Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial The Lancet

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, pha - The Lancet

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, pha The Lancet

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial - The Lancet

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial The Lancet

Companies like Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Société Française d'ORL - SFORL logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Société Française D'...

11
ILC - Institut inter-régionaL de Cancérologie logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Ilc - Institut Inter...

38
Unicancer logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Unicancer

378
SFjRO-Société Française des Jeunes Radiothérapeutes Oncologues logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Sfjro-Société França...

16
AFCOR_ Association de Formation Continue en Oncologie Radiothérapie logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Afcor_ Association D...

6
FFCD logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Ffcd

32
Gustave Roussy logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Gustave Roussy

2.76K
GERCOR logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Gercor

24
IFCT logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Ifct

52
SFRO - Société Française de Radiothérapie Oncologique logo - Similar company to Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou

Sfro - Société Franç...

7

Top Gortec - Groupe D'Oncologie Radiothérapie Tête Et Cou Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant